Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an urgent need for personalized therapies. PDA is the result of complex interactions between tumor molecular profile and metabolites produced by i...

Full description

Bibliographic Details
Main Authors: Laura Follia, Giulio Ferrero, Giorgia Mandili, Marco Beccuti, Daniele Giordano, Rosella Spadi, Maria Antonietta Satolli, Andrea Evangelista, Hiroyuki Katayama, Wang Hong, Amin A. Momin, Michela Capello, Samir M. Hanash, Francesco Novelli, Francesca Cordero
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
metabolism
cancer subtypes
transcriptomic data
glycolysis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00115/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00115/full

Similar Items